This useful conversation among the serotoninergic and central dopaminergic units has been demonstrated in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic outcomes of psilocybin [five].By lowering ROS concentrations, the extracts shown basic safety and protecting outcome versus ET-one induced oxidative stra